However, HCC-associated mutations or pathologically low expression of SPOP lead to aberrant stabilization of LMNB2, which in turn, directly induces PD-L1 transcription, thereby promoting tumor immune evasion of HCC. The gene discussed is SPOP; the disease is neoplasm.